logo
Select company
Select metric
$ -0.77EBIT per Share
VS
Market
24
Sector
56
Industry
71
History
85
$ 2.41Close
$ 1.95 - $ 5.35 52-Week Range
Ticker Information

Ticker

CRDF

Company Name

CARDIFF ONCOLOGY INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CARDIFF ONCOLOGY INC - EBIT per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CRDF - EBITPS Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT per ShareShare FactorWeighted Average Shares
6/30/2025$ -51.02M$ -0.77166.53M
3/31/2025$ -48.85M$ -0.73166.52M
12/31/2024$ -45.43M$ -0.95147.65M
9/30/2024$ -42.98M$ -0.92146.87M
6/30/2024$ -40.86M$ -0.91144.83M
3/31/2024$ -40.23M$ -0.9144.68M
12/31/2023$ -41.44M$ -0.93144.68M
9/30/2023$ -40.8M$ -0.91144.68M
6/30/2023$ -39.64M$ -0.89144.68M
3/31/2023$ -38.93M$ -0.87144.68M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CARDIFF ONCOLOGY INC's latest trailing twelve months (TTM) EBITPS stands at $ -0.73.
  • Over the past 5 years, CARDIFF ONCOLOGY INC's average EBITPS has been $ -0.82.
  • The median EBITPS for CARDIFF ONCOLOGY INC during this period was $ -0.88
  • CARDIFF ONCOLOGY INC reached its highest EBITPS over the past 5 years at $ -0.55.
  • The lowest EBITPS recorded by CARDIFF ONCOLOGY INC in the same timeframe $ -0.95

CARDIFF ONCOLOGY INC's EBITPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITPS Benchmarks
CompanyEBITPS
MREO : MEREO BIOPHARMA GROUP PLC $ -0.31AVTX : AVALO THERAPEUTICS INC $ -4.46HUMA : HUMACYTE INC $ -0.31COYA : COYA THERAPEUTICS INC $ -1.26VTGN : VISTAGEN THERAPEUTICS INC $ -1.75ABEO : ABEONA THERAPEUTICS INC $ 1.46ABVC : ABVC BIOPHARMA INC $ -0.16LYEL : LYELL IMMUNOPHARMA INC $ -22.4CURX : CURANEX PHARMACEUTICALS INC -MNPR : MONOPAR THERAPEUTICS $ -2.47

Similar metrics to Shares WA:

Definition of EBIT per Share

[Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBIT / (Shares WA * Share Factor)
(=) EBITPS EBITPS for CARDIFF ONCOLOGY INC is calculated as follows: EBIT [ $ -16.95M ] / (Shares WA [ 23.34M ] * Share Factor [ 1 ])
(=) EBITPS [ $ -0.73 ]

CRDF - EBIT per Share, Last 5 years

$ -0.95

Minimum

Dec 31, 2024

$ -0.55

Maximum

Mar 31, 2021

$ -0.82

Average

$ -0.88

Median

EBITPS Benchmark Analysis

 The chart above depicts the distribution of EBITPS for companies in the Total Stock Market. The average EBITPS of the companies is $ 1.16 with a standard deviation of $ 3.42.
The following table provides additional summary stats:
EBITPS in the Market:
filtered constituents3.79K
min$ -9.72
max$ 10.76
average$ 1.16
median$ 0.38
std$ 3.42